| Authors: |
Raffo-Iraolagoitia XL; Cancer Research UK Scotland Institute, Glasgow, UK., Alyamani A; Cancer Research UK Scotland Institute, Glasgow, UK., May S; Cancer Research UK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Stevenson D; Cancer Research UK Scotland Institute, Glasgow, UK., Mackintosh A; Cancer Research UK Scotland Institute, Glasgow, UK., McGarry L; Cancer Research UK Scotland Institute, Glasgow, UK., Anand J; Cancer Research UK Scotland Institute, Glasgow, UK., Soloviev D; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Brown G; Cancer Research UK Scotland Institute, Glasgow, UK., Nixon C; Cancer Research UK Scotland Institute, Glasgow, UK., Kapeni C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., De La Roche M; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Blyth K; Cancer Research UK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Bird TG; Cancer Research UK Scotland Institute, Glasgow, UK.; University of Edinburgh Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK., Strathdee D; Cancer Research UK Scotland Institute, Glasgow, UK., Lyons SK; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA., Fruhwirth G; Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Cancer Centre, London, UK., Carlin LM; Cancer Research UK Scotland Institute, Glasgow, UK.; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Lewis DY; Cancer Research UK Scotland Institute, Glasgow, UK. david.lewis@glasgow.ac.uk.; School of Cancer Sciences, University of Glasgow, Glasgow, UK. david.lewis@glasgow.ac.uk. |
